Podcasts about Amicus

SafeSport has suspended Al Fong for five years after a nearly six year long investigation, Melanie de Jesus dos Santos confirms her return ''to the gym'', and all the NCAA news to kick off the 2026 season. HEADLINES SafeSport has suspended Al Fong for five years after a nearly six year long investigation Armine was also suspended for one year after acting as the head coach of the Junior Worlds squad Both coaches were suspended for emotional and physical misconduct Listen to our interviews with Ivana Hong, Terin Humphrey, and Sarah Shire Brown, who talk about their time at GAGE under coach Al Fong  Melanie de Jesus dos Santos confirms her return ''to the gym'' according to her Instagram GYMTERNET NEWS More discontent brewing in France: 15-year-old Elena Colas, the junior world all-around silver medalist, declined a call-up to a French national team training camp in Martinique SafeSport Continues to Fail The AP finds SafeSport failed to finalize a lifetime ban against coach Sean Gardner despite abuse allegations Romanian Infighting An audio recording reveals Camelia Voinea urging supporters to attack coach Corina Moroșan, exposing a deep internal power struggle over how the gymnastics should be run in Romania OC Coach Arrested 25-year-old Jacob Alexander Demmin was arrested following an investigation into an alleged relationship with a girl under the age of 18 at Firestorm Freerunning. Ellie Freakin' Black finally getting the recognition she deserves Ellie Black was named to Order of Canada: the second-highest honor for merit in the system of orders, decorations, and medals of Canada NCAA The 2026 college season has begun! Is competing in the first week of the season a good idea? bad idea? The WORST idea? Jordan Chiles went 39.725 in week 1, leading the nation in the all-around standings, thoughts? UCLA is ranked no. 1 with a 196.975 How does UCLA's freshmen class fit into this picture? Missouri went 196.850, counting a fall on beam! Corrupt or Correct: Utah's scores, as covered on college and cocktails this week Clemson breaking into the 196s after the first meet is a win A triumph for vault variety! The first four vaults in Clemson's lineups were different Cal broke into the 196s, an important result for the team to show they aren't dead Leaps spotlight Paulina Vargas, sophomore at Oregon State, proving to us that nobody really cares if you only do a two-pass floor routine as long as your leaps look as good as hers Spotlight: The Show Nina Ballou at LSU's exhibition SOLD her dance through, bringing like 15 different celebrations during the intros Is it time to be worried? Iowa State's 191.325 is their lowest score since 1999 RELATED EPISODES Paris World Cup with Laura Cappelle Jakarta Worlds Debrief: The Romanian Drama Explained With Coaches Daymon Jones & Patrick Kiens 60: Terin Humphrey 26: Ivana Hong 358: Regionals Preview, Shire Brown, Olivera, Ruddock UP NEXT College & Cocktails: Saturday, Jan 10, 3pm Pacific, following Sprouts Quad session 1 (Oklahoma, UCLA, Utah, LSU) Add exclusive Club Content like College & Cocktails to your favorite podcast player (instructions here). SUPPORT OUR WORK  Join Club Gym Nerd (or give it as a gift!) for access to weekly Behind the Scenes episodes. Club Gym Nerd members can watch the podcast being recorded and get access to all of our exclusive extended interviews, Behind The Scenes and College & Cocktails. Not sure about joining the club?  College & Cocktails: The Friday Night NCAA Gymnastics Post-Meet Show is available to sample (even if you aren't a Club Gym Nerd member yet). Watch or listen here. Buy a Ticket to the Live Show with Cecile Landi and Levi WATCH REPLAY HERE : Buy a ticket now or buy it as a gift! If you purchased a ticket to the live show with Cecile Landi and Levi Jung-Ruivivar benefitting The National Eating Disorder Foundation you can still watch the replay.  Watch highlights before you buy here. 2026 LIVE SHOW SEASON PASSES ARE NOW AVAILABLE That's 4 live show passes for the price of 3! Season passes will be available up until the week of the first show. Buy a 2026 season pass here. MERCH GymCastic Store: clothing and gifts to let your gym nerd flag fly and even "tapestries" (banners, the perfect to display in an arena) to support your favorite gymnast! Baseball hats available now in the GymCastic store THANKS TO OUR SPONSORS Huel Daily Greens Ready to Drink – Get 20% off your purchase for New Customers with our exclusive code GYMCASTIC20 at https://huel.com/GYMCASTIC. Use our code and fill out the post checkout survey to help support the show! Thank you to our Sponsor: "Broken to Unbreakable" by Lori Vollkommer available on Amazon or wherever you buy your books NEWSLETTERS Sign up for all three GymCastic newsletters  FANTASY GAME: GymCastic 2026 College Fantasy Game now open. Never too late to join! RESOURCES Spencer's essential website The Balance Beam Situation  Gymnastics History and Code of Points Archive from Uncle Tim RESISTANCE  Submitted by our listeners. ACTION Indivisible Practical ideas about what you can actually do in this moment, check it out: indivisi.org/muskorus 5Calls App will call your Congresspeople by issue with a script to guide you Make 2 to your Congressional rep (local and DC office). 2 each to your US Senators (local and state offices) State your name and zip code or district Be concise with your question or demand (i.e. What specific steps is Senator X taking to stop XYZ) Wait for answer Ask for action items -  tell them what you want them to do (i.e. draft articles of impeachment immediately, I want to see you holding a press conference in front of...etc.) ResistBot Turns your texts into faxes, postal mail, or emails to your representatives in minutes LAWSUITS Donate to organizations suing the administration for illegal actions ACLU, Southern Poverty Law Center, Northwest Immigration Law Project STAY INFORMED Suggested podcasts:  Amicus, Daily Beans, Pod Save America, Strict Scrutiny Immigrant Rights Know Your Rights Red Cards, We Have Rights Video, Your Rights on trains and buses video  

Supreme Court expert and Amicus podcast host Dahlia Lithwick joins Marc Elias to unpack one of the most dangerous and least understood forces shaping American law today: the Supreme Court's shadow docket. Lithwick explains how the Court increasingly uses late-night, unsigned emergency orders to upend lower-court rulings, reverse longstanding precedent, and reshape democracy—without transparency, reasoning, or accountability. Together, they explore how the shadow docket amplifies minority rule, expands executive power, undermines voting rights, and allows the Court to exercise enormous authority while evading public scrutiny. Support independent journalism: https://newsletters.democracydocket.com/member-youtube Stay informed with the latest news and political analysis: https://newsletters.democracydocket.com/youtube Follow Democracy Docket: Bluesky: https://bsky.app/profile/democracydocket.com Instagram⁠: https://instagram.com/democracydocket Facebook⁠: https://facebook.com/democracydocket X/Twitter⁠: https://twitter.com/DemocracyDocket TikTok⁠: https://tiktok.com/@democracydocket Threads: https://www.threads.net/@democracydocket

In a special new year retrospective, Amicus host Dahlia Lithwick revisits an important episode from early 2025. Back at the beginning of February, Kim Lane Scheppele, the Laurance S. Rockefeller Professor of Sociology and International affairs at Princeton University, pointed to  the speed and viciousness of the very opening legal gambits in Trump 2.0 as evidence that America had already switched over to the fast track for autocracy on January 20th, 2025. An expert in the law of autocracy, Scheppele has seen firsthand what happened to constitutional courts, the media, the academy and the democratic norms that protected them in Russia and Hungary. In this interview, Scheppelle explains how Trump's executive orders on everything from government funding to transgender people in the military reveal a familiar global playbook that has chillingly familiar endpoints.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

In a special new year retrospective, Amicus host Dahlia Lithwick revisits an important episode from early 2025. Back at the beginning of February, Kim Lane Scheppele, the Laurance S. Rockefeller Professor of Sociology and International affairs at Princeton University, pointed to  the speed and viciousness of the very opening legal gambits in Trump 2.0 as evidence that America had already switched over to the fast track for autocracy on January 20th, 2025. An expert in the law of autocracy, Scheppele has seen firsthand what happened to constitutional courts, the media, the academy and the democratic norms that protected them in Russia and Hungary. In this interview, Scheppelle explains how Trump's executive orders on everything from government funding to transgender people in the military reveal a familiar global playbook that has chillingly familiar endpoints.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

In a special new year retrospective, Amicus host Dahlia Lithwick revisits an important episode from early 2025. Back at the beginning of February, Kim Lane Scheppele, the Laurance S. Rockefeller Professor of Sociology and International affairs at Princeton University, pointed to  the speed and viciousness of the very opening legal gambits in Trump 2.0 as evidence that America had already switched over to the fast track for autocracy on January 20th, 2025. An expert in the law of autocracy, Scheppele has seen firsthand what happened to constitutional courts, the media, the academy and the democratic norms that protected them in Russia and Hungary. In this interview, Scheppelle explains how Trump's executive orders on everything from government funding to transgender people in the military reveal a familiar global playbook that has chillingly familiar endpoints.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

Behzad Najafian, MD, Professor, Department of Laboratory Medicine & Pathology, Department of Medicine at the University of Washington, Washington, USA discusses the use of artificial intelligence in identifying and managing lysosomal disorders.This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available to other attendees.To obtain CME/CE credit, visit https://checkrare.com/learning/p-grids2025-session1-ai-in-medicine-transforming-the-landscape-of-tissue-based-diagnostics/Learning ObjectivesDescribe recent advances in the applications of AI in lysosomal disorder diagnosis and its clinical relevanceFacultyBehzad Najafian, MD Professor, Department of Laboratory Medicine & Pathology, Department of Medicine, University of WashingtonDisclosuresAffinityCE staff, LDRTC staff, planners, and reviewers, have no relevant financial relationships with ineligible companies to disclose. Faculty disclosures, listed below, will also be disclosed at the beginning of the Program.Behzad Najafian, MDDr. Najafian is on the Advisory Board/Consultant for Sanofi, Amicus, Avrobio, 4DMT,Sangamo, Freeline, AceLink, Relay, CRISPR, ELOXX, SPARK, UNIQURE. He receives grants/research support from Amicus. Mitigation of Relevant Financial RelationshipsAffinityCE adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Conflicts of interest for presenting faculty with relevant financial interests were resolved through peer review of content by a non-conflicted reviewer.Accreditation and Credit DesignationPhysiciansThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.AffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Physician AssistantsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.NursesAffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). This activity provides a maximum of 1 hours of continuing nursing education credit.Nurse PractitionersAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.Genetic CounselorsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Genetic Counselors should claim only the credit commensurate with the extent of their participation in the activity.Other ProfessionalsAll other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity. Participation CostsThere is no cost to participate in this activity.CME InquiriesFor all CME policy-related inquiries, please contact us at ce@affinityced.comSend customer support requests to cds_support+ldrtc@affinityced.com

Oral Alpan, MD, Immunologist, Amerimmune, Virginia, USA; Svenja Keller, PhD student, University of Zurich, Switzerland; Shoshana Revel-Vilk, MD, PhD, Director, Gaucher Unit & Pediatric Hematology/Oncology Unit, Shaare Zedek Medical Center, Jerusalem, Israel; Patrick Deegan, MD, Consultant Metabolic Physician, University of Cambridge, UK; and Ravi Kamath, MD, PhD, Head of Musculoskeletal Radiology, Inova Health System, Virginia, USA, discuss the applications of AI in the diagnosis and treatment of lysosomal disorders.This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available to other attendees.To obtain CME/CE credit, visit https://checkrare.com/learning/p-grids2025-session4-expanded-applications-of-ai-in-lysosomal-disorders/Learning ObjectivesDescribe how emerging AI and machine learning technologies are advancing disease modeling and biomarker development.Describe how emerging AI and machine learning technologies are advancing therapeutic target identification across lysosomal disorders.FacultyOral Alpan, MD, Immunologist, AmerimmuneSvenja Keller, PhD student, University of ZurichShoshana Revel-Vilk, MD, PhD, Director, Gaucher Unit & Pediatric Hematology/Oncology Unit, Shaare Zedek Medical CenterPatrick Deegan, MD, Consultant Metabolic Physician, University of CambridgeRavi Kamath, MD, PhD, Head of Musculoskeletal Radiology, Inova Health SystemDisclosuresAffinityCE staff, LDRTC staff, planners, and reviewers, have no relevant financial relationships with ineligible companies to disclose. Faculty disclosures, listed below, will also be disclosed at the beginning of the Program.Oral Alpan, MD Dr. Alpan has no relevant financial relationships to disclose.Svenja KellerMs. Keller has no relevant financial relationships to disclose.Shoshana Revel-Vilk, MD, PhDDr. Revel-Vilk receives grant/research support from Sanofi and Takeda. She is a member of the Speakers Bureau for Sanofi and Takeda, and a member of the Advisory Board for Takeda.Patrick Deegan, MDDr. Deegan is a consultant and advisory board member with Sanofi, Takeda, and Amicus.He also receives research support from Sanofi and Amicus.Ravi Kamath, MD, PhDDr. Kamath is on an advisory board for Intrinsic Therapeutics. He is also a consultant forSanofi, Takeda, and Spur Therapeutics.Mitigation of Relevant Financial RelationshipsAffinityCE adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Conflicts of interest for presenting faculty with relevant financial interests were resolved through peer review of content by a non-conflicted reviewer.Accreditation and Credit DesignationPhysiciansThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.AffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Physician AssistantsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.NursesAffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). This activity provides a maximum of 1 hours of continuing nursing education credit.Nurse PractitionersAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.Genetic CounselorsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Genetic Counselors should claim only the credit commensurate with the extent of their participation in the activity.Other ProfessionalsAll other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity. Participation CostsThere is no cost to participate in this activity.CME InquiriesFor all CME policy-related inquiries, please contact us at ce@affinityced.comSend customer support requests to cds_support+ldrtc@affinityced.com

VLOG 1 Dec 30 Diddy docket has amicus brief, Diddy Do It? https://www.amazon.com/dp/B0DHP7YF19Crypto: US wants 12 years on SafeMoon Karony https://www.patreon.com/posts/146958728TN news: Kilmar sanctions, Pinnacle-Synovus rubberstamp. New UN disgrace series https://matthewrussellleeicp.substack.com/p/extra-guterres-bought-off-overseeing

Over the past calendar year, the Supreme Court's center has shifted to the right and then more to the right, and the justices' decisions have time and again facilitated Trump's agenda. But the Roberts majority is not simply focused on what the current president wants; it has its sights set on a larger project: voting. Suppressing and constraining and problematizing the core function of democratic rule. In this episode, Dahlia Lithwick and Mark Joseph Stern reflect on the significant developments at  the Supreme Court over the past year with an eye toward the implications of the court's decisions on democracy, voting rights, and the erosion of checks and balances. Looking back at the past year at One First Street, Dahlia and Mark trace the cases that reveal the court's long game, with elections coming quickly, and discuss the forces for and against democracy being exerted within and without the high court. Then, they turn to the urgent matter of what you and I can do about it. If you want to access that special 50% discount for Slate Plus membership, go to slate.com/amicusplus and enter promo code AMICUS 50.  This offer expires on Dec 31st 2025. Learn more about your ad choices. Visit megaphone.fm/adchoices

Over the past calendar year, the Supreme Court's center has shifted to the right and then more to the right, and the justices' decisions have time and again facilitated Trump's agenda. But the Roberts majority is not simply focused on what the current president wants; it has its sights set on a larger project: voting. Suppressing and constraining and problematizing the core function of democratic rule. In this episode, Dahlia Lithwick and Mark Joseph Stern reflect on the significant developments at  the Supreme Court over the past year with an eye toward the implications of the court's decisions on democracy, voting rights, and the erosion of checks and balances. Looking back at the past year at One First Street, Dahlia and Mark trace the cases that reveal the court's long game, with elections coming quickly, and discuss the forces for and against democracy being exerted within and without the high court. Then, they turn to the urgent matter of what you and I can do about it. If you want to access that special 50% discount for Slate Plus membership, go to slate.com/amicusplus and enter promo code AMICUS 50.  This offer expires on Dec 31st 2025. Learn more about your ad choices. Visit megaphone.fm/adchoices

Over the past calendar year, the Supreme Court's center has shifted to the right and then more to the right, and the justices' decisions have time and again facilitated Trump's agenda. But the Roberts majority is not simply focused on what the current president wants; it has its sights set on a larger project: voting. Suppressing and constraining and problematizing the core function of democratic rule. In this episode, Dahlia Lithwick and Mark Joseph Stern reflect on the significant developments at  the Supreme Court over the past year with an eye toward the implications of the court's decisions on democracy, voting rights, and the erosion of checks and balances. Looking back at the past year at One First Street, Dahlia and Mark trace the cases that reveal the court's long game, with elections coming quickly, and discuss the forces for and against democracy being exerted within and without the high court. Then, they turn to the urgent matter of what you and I can do about it. If you want to access that special 50% discount for Slate Plus membership, go to slate.com/amicusplus and enter promo code AMICUS 50.  This offer expires on Dec 31st 2025. Learn more about your ad choices. Visit megaphone.fm/adchoices

Merry Christmas! In another gem from the archives of A Very British Horror, Chris and Paul discuss BBC-TV's classic 1976 Ghost Story for Christmas, The Signalman, based on the story by Charles Dickens. Plus there's a short update from Dan about what will come next from the main podcast.   Works Cited   The Signalman (BBC-TV 1976, director: Lawrence Gordon Clark) A Ghost Story for Christmas: The Room in The Tower (BBC-TV 2025, director: Mark Gatiss) is currently available on BBC iPlayer   A rough cut of our January episode, in which Howard and Dan discuss Amicus films, is now available for supporters on our Patreon page

There's still time in the year to hear from leaders and advocates in the sexual and reproductive health and rights field! On this episode of our most popular series, SRHR Hero Origin Stories, we talk to a number of amazing heroes in the field of reproductive health, rights, and justice about how they began working in this space. On this episode, hear from Lupe Rodriguez, Executive Director of the National Latina Institute for Reproductive Justice, Dr. Monica McLemore, Professor at New York University's Rory Meyer's College of Nursing, Samira Damavandi, Senior Policy Associate for Federal Issues at the Guttmacher Institute, and Jennie Wetter, Director and Host of rePROs Fight Back.If you haven't already, check out our previous episodes, SRHR Hero Origin Stories: Round 7, SRHR Hero Origin Stories: Round 6, SRHR Origin Stories: Round 5, and more.For more information, check out Amicus with Dhalia Lithwick: https://slate.com/podcasts/amicusSupport the showFollow Us on Social: Twitter: @rePROsFightBack Instagram: @reprosfbFacebook: rePROs Fight Back Bluesky: @reprosfightback.bsky.social Buy rePROs Merch: Bonfire store Email us: jennie@reprosfightback.comRate and Review on Apple PodcastThanks for listening & keep fighting back!

VLOG Dec 23: @USUN on Somalia day after Cholo Abdullah gets life sentence https://matthewrussellleeicp.substack.com/p/extra-life-in-prison-for-man-whoEDNY Sun mistrial, crypto bros amicus DeFi Ed Fund https://www.patreon.com/posts/crypto-in-courts-146328698OCC blank check Erebor, Park National, as @FinanceWatchOrg hits Burke & Herbert/Link https://innercitypress.com/unspun1haysomnoshowbluewashedicp122425.htmlUN Haysom scam https://innercitypress.com/unspun1haysomnoshowbluewashedicp122425.html @USAmbUN and UN's Press ban

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.In a dynamic landscape marked by both advancements and challenges, the pharmaceutical and biotech sectors continue to evolve with notable scientific, regulatory, and strategic updates. Ipsen's recent $1 billion acquisition of Simcere's preclinical LRRC15-targeting asset underscores a growing focus on antibody-drug conjugates (ADCs). These conjugates leverage the targeted action of antibodies combined with the cytotoxic effects of drugs, representing a promising approach to cancer treatment by potentially minimizing systemic toxicity. Ipsen's strategic move reflects its commitment to expanding its oncology portfolio and staying competitive within the rapidly advancing ADC landscape.AstraZeneca has been active in its pursuit of innovative cancer treatments. The company has invested $100 million in Jacobio's clinical-stage pan-KRAS inhibitor, a promising development targeting KRAS mutations prevalent in various cancers. This investment aligns with AstraZeneca's strategy to tackle challenging oncogenic targets. However, their efforts faced a setback as their Phase 3 trial for ceralasertib, an ATR inhibitor for lung cancer, failed to meet its primary endpoint. Despite this setback, AstraZeneca maintains confidence by investing significantly in promising areas like KRAS inhibitors, highlighting the inherent risks involved in pioneering novel therapeutic strategies, particularly those aiming to overcome resistance mechanisms in immuno-oncology.BioMarin has quietly discontinued its liver disease candidate amid a $4.8 billion deal with Amicus. This decision points to the complex nature of pipeline prioritization and resource allocation within high-stakes financial environments. The company's strategic shifts reflect ongoing evaluations of their development priorities in light of evolving market demands.Boehringer Ingelheim has demonstrated a commitment to renal therapeutics with a $448 million investment in Rectify Pharmaceuticals for a preclinical chronic kidney disease program. This partnership seeks to address significant unmet medical needs within kidney disease treatment. Meanwhile, Gilead Sciences has entered into a $35 million licensing agreement with Assembly Biosciences for herpes simplex virus (HSV) assets, diversifying its infectious disease portfolio and expanding its reach within antiviral therapies.Novo Holdings-backed Windward Bio's acquisition of rights to Qyun's clinical-stage immunology bispecifics for $700 million highlights robust activity in the immunology space. Bispecific antibodies are gaining traction due to their ability to target two antigens simultaneously, offering enhanced therapeutic efficacy. This acquisition illustrates ongoing interest in this area as companies seek innovative solutions to complex immunological challenges.The broader industry is also witnessing strategic partnerships such as Aditum Bio's launch of a new biotech venture with Fosun Pharma. This collaboration aims to foster novel therapies through a synergistic blend of biotechnology innovation and pharmaceutical expertise. These alliances reflect an industry trend towards collaborative efforts that leverage diverse strengths to advance therapeutic development.In regulatory news, nine major pharmaceutical companies have reached agreements with the U.S. government to lower certain drug prices in exchange for tariff relief. This development signals ongoing negotiations aimed at balancing drug affordability with industry sustainability amid growing scrutiny over pricing practices.In December 2025, significant developments emerged, impacting scientific innovation, regulatory approvals, mergers, and strategic partnerships across the industry. Notably, the U.S. Food and Drug Administration (FDA) granted early approval to Cytokinetics' MyqorzSupport the show

Nothing says Christmas like a killer Santa Claus! "...And All Through the House" is just one highly effective tale from the five-story anthology film from Amicus, Tales from the Crypt (1972.) The characters in each one of them get what's coming to them, whether it's because they're husband killers, wife cheaters, greedy real estate investors, ruthless financiers, or selfish directors of a home for the blind. Join Richard, Jeff, and the Cryptkeeper in watching their stories and judging their fates. Maybe you'll learn a lesson or two... these despicable human beings do not.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. In the ever-evolving landscape of pharmaceuticals and biotechnology, a series of strategic transactions and scientific advancements are reshaping the industry.BioMarin's acquisition of Amicus Therapeutics for $4.8 billion is a significant highlight, marking the company's largest transaction to date. This move signifies a strategic pivot towards enhancing its capabilities in the rare disease sector, leveraging Amicus's expertise and robust pipeline to potentially improve patient outcomes in this highly specialized area. This acquisition is expected to enrich BioMarin's portfolio significantly with promising assets from Amicus, reflecting a strategic shift under new leadership towards rare disease treatments.Regulatory affairs have seen considerable activity as well, with the FDA raising concerns over manufacturing practices at Catalent's gene therapy facility. These issues, documented in a Form 483 following inspections, particularly pertain to the production of Elevidys. Such regulatory scrutiny emphasizes the critical importance of maintaining compliance with manufacturing standards in gene therapy—a burgeoning field within biotech that holds immense promise for treating genetically-driven conditions.The FDA's oversight extends beyond manufacturing practices to advertising, as evidenced by an untitled letter issued to Bristol Myers Squibb regarding their Cobenfy TV ad. This action is part of the FDA's broader initiative to ensure that direct-to-consumer marketing materials accurately portray drug benefits and risks, thereby protecting public health.In another strategic move, Alvotech and Teva are gearing up for the 2026 U.S. launch of an Eylea biosimilar following a settlement with Regeneron. This development highlights the competitive dynamics within the biosimilar market—a segment poised for growth as patents on major biologics expire, offering more cost-effective alternatives and expanding treatment access.Meanwhile, Clovis Oncology has achieved a milestone with Rubraca, which transitioned from accelerated approval to full FDA endorsement for prostate cancer treatment after five years. This progression underscores Rubraca's demonstrated efficacy and safety profile in addressing advanced prostate cancer—a notable achievement amid an increasingly competitive oncology market.Policy changes proposed by Health and Human Services Secretary Robert F. Kennedy Jr. could have profound implications by disrupting funding streams for hospitals providing gender-affirming care to minors. The potential impact on healthcare providers and patients who rely on these services is significant.Turning to clinical trials, Daiichi Sankyo has seen success with Enhertu receiving FDA approval for first-line HER2-positive breast cancer treatment. Nonetheless, challenges persist as a separate phase 3 trial for another antibody-drug conjugate was paused due to unexpected patient deaths. Meanwhile, Takeda plans to seek FDA approval for its TYK2 inhibitor following successful phase 3 trials in psoriasis—indicating promising potential in autoimmune disease therapies.Strategic shifts are evident across organizations as well, highlighted by Kathy Fernando's departure from Pfizer to join Replicate Bioscience as Chief Business Officer. Her new role focuses on advancing Replicate's self-replicating RNA technology platform—an area gaining traction due to its implications for vaccine development and therapeutic applications.On the clinical trials front, Altimmune reported encouraging results from a 48-week study on metabolic dysfunction-associated steatohepatitis (MASH). Their GLP-1/glucagon dual receptor agonist demonstrated sustained weight loss and improvements in non-invasive liver fibrosis measures—offering new hope for MASH patients who face limited treSupport the show

In mid-March of 2025, ACLU attorney Lee Gelernt and his colleagues started hearing that the Trump administration might attempt a flagrantly lawless publicity stunt, involving migrant men, secret flights to El Salvador, a notorious gulag, and a total disregard for due process. Despite getting word that something was about to happen, and rushing into a Saturday night hearing, and then securing a TRO from DC judge James Boasberg, Lee and his colleagues were unable to prevent more than 250 men from being renditioned from Texas to the CECOT torture prison in El Salvador. The legal cases spawned by the dramatic events of March 15th 2025 haven't gone away, indeed they are reaching crucial milestones in the courts, raising foundational questions about the abuse of statutes and what it means to defy court orders. On this week's Amicus, Dahlia Lithwick is joined by the ACLU's Lee Gelernt who is litigating these cases, to discuss the very high stakes of a set of cases that may have fallen off your radar in the shuffle.  How these cases play out will dictate much of what happens for the rest of Trump's term in office by answering democracy-defining questions such as whether the antiquated and radical wartime powers of the Alien Enemies Act can be unleashed on people the government deems enemies domestically, whether court orders are actually directives the Trump DoJ is bound  to follow, whether the district courts can require Pam Bondi's justice department to assist in the finding of fact, and whether the ancient legal concepts protecting liberty of due process and habeas corpus have the force of law in Trump's America.  If you want to access that special 50% promotion for Slate Plus membership, go to slate.com/amicusplus and enter promo code AMICUS 50.  This offer expires on Dec 31st 2025. Learn more about your ad choices. Visit megaphone.fm/adchoices

In mid-March of 2025, ACLU attorney Lee Gelernt and his colleagues started hearing that the Trump administration might attempt a flagrantly lawless publicity stunt, involving migrant men, secret flights to El Salvador, a notorious gulag, and a total disregard for due process. Despite getting word that something was about to happen, and rushing into a Saturday night hearing, and then securing a TRO from DC judge James Boasberg, Lee and his colleagues were unable to prevent more than 250 men from being renditioned from Texas to the CECOT torture prison in El Salvador. The legal cases spawned by the dramatic events of March 15th 2025 haven't gone away, indeed they are reaching crucial milestones in the courts, raising foundational questions about the abuse of statutes and what it means to defy court orders. On this week's Amicus, Dahlia Lithwick is joined by the ACLU's Lee Gelernt who is litigating these cases, to discuss the very high stakes of a set of cases that may have fallen off your radar in the shuffle.  How these cases play out will dictate much of what happens for the rest of Trump's term in office by answering democracy-defining questions such as whether the antiquated and radical wartime powers of the Alien Enemies Act can be unleashed on people the government deems enemies domestically, whether court orders are actually directives the Trump DoJ is bound  to follow, whether the district courts can require Pam Bondi's justice department to assist in the finding of fact, and whether the ancient legal concepts protecting liberty of due process and habeas corpus have the force of law in Trump's America.  If you want to access that special 50% promotion for Slate Plus membership, go to slate.com/amicusplus and enter promo code AMICUS 50.  This offer expires on Dec 31st 2025. Learn more about your ad choices. Visit megaphone.fm/adchoices

In mid-March of 2025, ACLU attorney Lee Gelernt and his colleagues started hearing that the Trump administration might attempt a flagrantly lawless publicity stunt, involving migrant men, secret flights to El Salvador, a notorious gulag, and a total disregard for due process. Despite getting word that something was about to happen, and rushing into a Saturday night hearing, and then securing a TRO from DC judge James Boasberg, Lee and his colleagues were unable to prevent more than 250 men from being renditioned from Texas to the CECOT torture prison in El Salvador. The legal cases spawned by the dramatic events of March 15th 2025 haven't gone away, indeed they are reaching crucial milestones in the courts, raising foundational questions about the abuse of statutes and what it means to defy court orders. On this week's Amicus, Dahlia Lithwick is joined by the ACLU's Lee Gelernt who is litigating these cases, to discuss the very high stakes of a set of cases that may have fallen off your radar in the shuffle.  How these cases play out will dictate much of what happens for the rest of Trump's term in office by answering democracy-defining questions such as whether the antiquated and radical wartime powers of the Alien Enemies Act can be unleashed on people the government deems enemies domestically, whether court orders are actually directives the Trump DoJ is bound  to follow, whether the district courts can require Pam Bondi's justice department to assist in the finding of fact, and whether the ancient legal concepts protecting liberty of due process and habeas corpus have the force of law in Trump's America.  If you want to access that special 50% promotion for Slate Plus membership, go to slate.com/amicusplus and enter promo code AMICUS 50.  This offer expires on Dec 31st 2025. Learn more about your ad choices. Visit megaphone.fm/adchoices

Feminist foreign policy is a policy framework that challenges traditional understandings of foreign policy. It prioritizes peace, gender equality, human rights, and environmental integrity. Jill Montilla, Development and Communications Associate with the Feminist Foreign Policy Collaborative and Spogmay Ahmed, Senior Policy Advisor with the Feminist Foreign Policy Collaborative, sit down to talk with us about why a framework that disrupts colonial, racist, patriarchal, and male-dominated power structures is critical.Upwards of 15 global governments have formally committed to utilizing a feminist foreign policy, and many more have engaged with the topic in multilateral settings. A recent, re-occurring report from the Feminist Foreign Policy Collaboration, which analyses over 20 countries' commitment to feminist foreign policy, found that these policies have survived more elections than they have lost, that several countries have expanded their commitments, and that several countries have increased multilateral, bilateral, and regional activity. Many governments have taken up sexual and reproductive health and rights, in particular, as a priority. Some countries have stepped back from their commitments, though, amongst a troubled landscape for funding. For more information, check out Amicus with Dhalia Lithwick: https://slate.com/podcasts/amicusSupport the showFollow Us on Social: Twitter: @rePROsFightBack Instagram: @reprosfbFacebook: rePROs Fight Back Bluesky: @reprosfightback.bsky.social Buy rePROs Merch: Bonfire store Email us: jennie@reprosfightback.comRate and Review on Apple PodcastThanks for listening & keep fighting back!

Trump decided this past week that there was no downside to fully embracing the racist “shithole countries” rhetoric he denied seven years ago; but this mask coming fully off is just the latest chapter in a decades-long campaign to gut a very specific part of the constitution: the reconstruction amendments. On this week's Amicus episode, Dahlia Lithwick talks to civil rights attorney Sherrilyn Ifill about the critical role the 14th Amendment has played in shaping American democracy, and why this full frontal assault on its protections should have everyone on high alert. In a week in which we found ourselves toggling between “the tide is turning!” and “all is lost!” Sherrilyn expertly guides us to an  understanding of what winning looks like in this moment, and how the courts can still play a role in renewing America's commitment to equal justice under the law, even when the Supreme Court is openly hostile to that proposition.  Sherrilyn Ifill's substack newsletter: Is It Too Late? If you want to access that special 50% promotion for Slate Plus membership, go to slate.com/amicusplus and enter promo code AMICUS 50.  This offer expires on Dec 31st 2025. Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

Trump decided this past week that there was no downside to fully embracing the racist “shithole countries” rhetoric he denied seven years ago; but this mask coming fully off is just the latest chapter in a decades-long campaign to gut a very specific part of the constitution: the reconstruction amendments. On this week's Amicus episode, Dahlia Lithwick talks to civil rights attorney Sherrilyn Ifill about the critical role the 14th Amendment has played in shaping American democracy, and why this full frontal assault on its protections should have everyone on high alert. In a week in which we found ourselves toggling between “the tide is turning!” and “all is lost!” Sherrilyn expertly guides us to an  understanding of what winning looks like in this moment, and how the courts can still play a role in renewing America's commitment to equal justice under the law, even when the Supreme Court is openly hostile to that proposition.  Sherrilyn Ifill's substack newsletter: Is It Too Late? If you want to access that special 50% promotion for Slate Plus membership, go to slate.com/amicusplus and enter promo code AMICUS 50.  This offer expires on Dec 31st 2025. Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

Trump decided this past week that there was no downside to fully embracing the racist “shithole countries” rhetoric he denied seven years ago; but this mask coming fully off is just the latest chapter in a decades-long campaign to gut a very specific part of the constitution: the reconstruction amendments. On this week's Amicus episode, Dahlia Lithwick talks to civil rights attorney Sherrilyn Ifill about the critical role the 14th Amendment has played in shaping American democracy, and why this full frontal assault on its protections should have everyone on high alert. In a week in which we found ourselves toggling between “the tide is turning!” and “all is lost!” Sherrilyn expertly guides us to an  understanding of what winning looks like in this moment, and how the courts can still play a role in renewing America's commitment to equal justice under the law, even when the Supreme Court is openly hostile to that proposition.  Sherrilyn Ifill's substack newsletter: Is It Too Late? If you want to access that special 50% promotion for Slate Plus membership, go to slate.com/amicusplus and enter promo code AMICUS 50.  This offer expires on Dec 31st 2025. Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

These remarks are part of the 25th Anniversary Dinner: https://www.sermonaudio.com/news/25th-anniversary-dinner-report

Impending Medicaid cuts, the One Big Beautiful Bill Act's defunding of Planned Parenthood, and the freezing of Title X funding have fueled clinic closures across rural areas. Ashley Kurzweil, Senior Policy Analyst for Reproductive Health and Rights at the National Partnership for Women and Families and Sarah Coombs, Director for Health System Transformation at the National Partnership for Women and Families sit down to talk with us about the future of rural hospitals and clinics and the patients they care for.  Many Medicaid cuts will take effect in January of 2027. One of the most immediate impacts of the law is the failure to extend premium tax credits-- which helps those who do not have access to Medicaid or employer-sponsored health coverage-- afford marketplace coverage. Rural residents, who have higher rates of Medicaid coverage and benefits from enhanced ACA premium tax credits, will be disproportionately affected. Increased financial strain will be placed on these rural hospitals, and maternal health programs, labor and delivery units, and reproductive health care clinics will be dire in rural areas. This will disproportionality impact Black communities, indigenous communities, and Latina communities, as well as rural health workers.For more information, check out Amicus with Dhalia Lithwick: https://slate.com/podcasts/amicusSupport the showFollow Us on Social: Twitter: @rePROsFightBack Instagram: @reprosfbFacebook: rePROs Fight Back Bluesky: @reprosfightback.bsky.social Buy rePROs Merch: Bonfire store Email us: jennie@reprosfightback.comRate and Review on Apple PodcastThanks for listening & keep fighting back!

Well Ho Ho Ho (to quote Santa when he was counting your three mums), it's Christmas! Weirdly enough for a LoG-worshipping podcast, we've never actually got round to “The League of Gentlemen's Christmas Special” (also known as “You'll Never Leave”). Which is a tad strange as this was the time when the League truly revealed and revelled in their love of horror; with references galore in an anthology structure honouring the greats of Amicus; and three twisted tales that looked forward to where the Gents were heading in their subsequent careers, whilst also being worthy of inclusion in a “serious” horror anthology. Watch (or re-watch) to avoid spoilers and join us.

While the Secretary of Defense pursues lawless boat strikes with a laser focus on maximum trolling, the Supreme Court is working to undermine voting rights with a laser focus on maximum support for Republicans.  In this week's episode of Amicus, Dahlia Lithwick and co-host Mark Joseph Stern discuss the news that Trump's extra-constitutional attempt to restrict birthright citizenship is heading back to the Supreme Court. They also discuss Thursday's shadow docket decision supercharging racial gerrymandering as well as next week's campaign finance case that promises to unleash even more dark money in the midterms. Next, Dahlia's joined by Malcolm Nance, former naval intelligence officer, author and host of the Black Man Spy podcast to talk through the current administration's riding roughshod over established military law, and the very nasty history of bombing shipwrecks.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

While the Secretary of Defense pursues lawless boat strikes with a laser focus on maximum trolling, the Supreme Court is working to undermine voting rights with a laser focus on maximum support for Republicans.  In this week's episode of Amicus, Dahlia Lithwick and co-host Mark Joseph Stern discuss the news that Trump's extra-constitutional attempt to restrict birthright citizenship is heading back to the Supreme Court. They also discuss Thursday's shadow docket decision supercharging racial gerrymandering as well as next week's campaign finance case that promises to unleash even more dark money in the midterms. Next, Dahlia's joined by Malcolm Nance, former naval intelligence officer, author and host of the Black Man Spy podcast to talk through the current administration's riding roughshod over established military law, and the very nasty history of bombing shipwrecks.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

While the Secretary of Defense pursues lawless boat strikes with a laser focus on maximum trolling, the Supreme Court is working to undermine voting rights with a laser focus on maximum support for Republicans.  In this week's episode of Amicus, Dahlia Lithwick and co-host Mark Joseph Stern discuss the news that Trump's extra-constitutional attempt to restrict birthright citizenship is heading back to the Supreme Court. They also discuss Thursday's shadow docket decision supercharging racial gerrymandering as well as next week's campaign finance case that promises to unleash even more dark money in the midterms. Next, Dahlia's joined by Malcolm Nance, former naval intelligence officer, author and host of the Black Man Spy podcast to talk through the current administration's riding roughshod over established military law, and the very nasty history of bombing shipwrecks.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

It's that time of year again! Ready for a reprisal of our most popular series, SRHR Hero Origin Stories? If you haven't already, check out our previous episodes, SRHR Hero Origin Stories: Round 6, SRHR Origin Stories: Round 5, SRHR Hero Origin Stories: Round 4, and more, where we talk to a number of amazing heroes in the field of reproductive health, rights, and justice and about how they began working in this space. On this episode, hear from Christina Krysinski, Associate Director for Global Advocacy at Planned Parenthood Federation of America and Planned Parenthood Action Fund, Asha Dahya, filmmaker, reproductive rights and freedom advocate, and mother of two, and Rachel Marchand, Senior Policy Analyst and Podcast Producer at rePROs Fight Back.For more information, check out Amicus with Dhalia Lithwick: https://slate.com/podcasts/amicusSupport the showFollow Us on Social: Twitter: @rePROsFightBack Instagram: @reprosfbFacebook: rePROs Fight Back Bluesky: @reprosfightback.bsky.social Buy rePROs Merch: Bonfire store Email us: jennie@reprosfightback.comRate and Review on Apple PodcastThanks for listening & keep fighting back!

By design –  and also by dint of unbridled, undisciplined extremist exuberance – Donald Trump's second stint in the White House is thus far a tricky thing to characterize. While many of the administration's moves seem copy/pasted from a manual for authoritarian takeover, they're also deeply rooted in longstanding structural democratic deficits in America. For their part, The administration's boosters argue this whiplash-inducing dismantling of institutions, norms and precedents are simply the right's answer to similarly seismic constitutional shifts in the New Deal and Civil Rights eras. In a recent piece in the Boston Review, What Are We Living Through?, law professors Jedediah Britton-Purdy and David Pozen try to puzzle through these conflicting narratives of change. They join Dahlia Lithwick on this week's Amicus to map this moment and to plot paths through it.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

By design –  and also by dint of unbridled, undisciplined extremist exuberance – Donald Trump's second stint in the White House is thus far a tricky thing to characterize. While many of the administration's moves seem copy/pasted from a manual for authoritarian takeover, they're also deeply rooted in longstanding structural democratic deficits in America. For their part, The administration's boosters argue this whiplash-inducing dismantling of institutions, norms and precedents are simply the right's answer to similarly seismic constitutional shifts in the New Deal and Civil Rights eras. In a recent piece in the Boston Review, What Are We Living Through?, law professors Jedediah Britton-Purdy and David Pozen try to puzzle through these conflicting narratives of change. They join Dahlia Lithwick on this week's Amicus to map this moment and to plot paths through it.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

By design –  and also by dint of unbridled, undisciplined extremist exuberance – Donald Trump's second stint in the White House is thus far a tricky thing to characterize. While many of the administration's moves seem copy/pasted from a manual for authoritarian takeover, they're also deeply rooted in longstanding structural democratic deficits in America. For their part, The administration's boosters argue this whiplash-inducing dismantling of institutions, norms and precedents are simply the right's answer to similarly seismic constitutional shifts in the New Deal and Civil Rights eras. In a recent piece in the Boston Review, What Are We Living Through?, law professors Jedediah Britton-Purdy and David Pozen try to puzzle through these conflicting narratives of change. They join Dahlia Lithwick on this week's Amicus to map this moment and to plot paths through it.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

No one's health experiences exist in a vacuum. Individuals live multifaceted lives and often have multiple, intersecting health concerns. Our health influences our lives, and our lives (including our economic realities) influence our health. Nourbese Flint, President of All* Above All and All* in All Action Fund, sits down to talk with us about how comprehensive reproductive justice, including abortion access, requires economic security.  To achieve full reproductive justice, people need access to abortion care. To access abortion care, people need economic security. Being unable to access abortion can lead to a host of negative outcomes, including but not limited to economic insecurity. In the U.S., money and access to healthcare go hand-in-hand. The Hyde Amendment refuses to cover abortion care for those who receive their insurance from the federal government, forcing specific people to pay out-of-pocket for an abortion. And, more broadly, general healthcare continues to be impacted by the government shutdown, which was negotiated on the back of Affordable Care Act subsidies. Since Trump's second inauguration, funding freezes have impacted vast swaths of those working in sexual and reproductive health and rights both in the U.S. and abroad. General healthcare is not, in any way, disconnected from abortion access, and both issues closely intertwine. Maternal health, obstetrics, delivery, rural hospitals, and more are also impacted. For more information, check out Amicus with Dhalia Lithwick: https://slate.com/podcasts/amicusSupport the showFollow Us on Social: Twitter: @rePROsFightBack Instagram: @reprosfbFacebook: rePROs Fight Back Bluesky: @reprosfightback.bsky.social Buy rePROs Merch: Bonfire store Email us: jennie@reprosfightback.comRate and Review on Apple PodcastThanks for listening & keep fighting back!

Dahlia Lithwick is joined by former federal prosecutor Mimi Rocah, who brings her extensive experience trying and supervising federal criminal cases to a discussion of what the survivors of Jeffrey Epstein's sexual abuse can teach us about justice. She suggests that the Trump administration's eleventh-hour switchback tactic of calling for investigations of only Democrats speaks volumes about how the Justice Department is functioning these days, proving that vindictive prosecutions are the only game in town, bonus if they also have the effect of power-washing the president's shadow from the scandal. Next, they turn to the extraordinary scenes in a Virginia courtroom this week, as the DOJ's case against former FBI director and Trump foe James Comey seemed ready  to fall apart at the seams. As this administration's practice of political interference in legal proceedings is supercharged by dear leader's “Dear Pam”  posts to “his” AG Pam Bondi, this conversation highlights why judicial integrity and the ever-expanding ranks of judges refusing to accept lies, are among the last best hopes for equal justice under the law in America.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Dahlia Lithwick is joined by former federal prosecutor Mimi Rocah, who brings her extensive experience trying and supervising federal criminal cases to a discussion of what the survivors of Jeffrey Epstein's sexual abuse can teach us about justice. She suggests that the Trump administration's eleventh-hour switchback tactic of calling for investigations of only Democrats speaks volumes about how the Justice Department is functioning these days, proving that vindictive prosecutions are the only game in town, bonus if they also have the effect of power-washing the president's shadow from the scandal. Next, they turn to the extraordinary scenes in a Virginia courtroom this week, as the DOJ's case against former FBI director and Trump foe James Comey seemed ready  to fall apart at the seams. As this administration's practice of political interference in legal proceedings is supercharged by dear leader's “Dear Pam”  posts to “his” AG Pam Bondi, this conversation highlights why judicial integrity and the ever-expanding ranks of judges refusing to accept lies, are among the last best hopes for equal justice under the law in America.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Liz and Rebecca cover Chiles v. Salazar, the case before the Supreme Court seeking to strike down a Colorado law banning mental health professionals from practicing "conversion therapy" on children. They explain the details of the case and discuss the hypocrisy of a ruling striking down the ban. They also recount the October 7th oral arguments, where the majority of justices signaled support for a ruling that will nullify state laws in half the country protecting LGBTQ youth from these discredited harmful practices.   Background Oral argument transcript Tenth Circuit Opinion  SCOTUSblog page Amicus briefs Americans United FFRF SCOTUSblog - "Does Colorado's "conversion therapy" ban violate free speech?" The Trevor Project - "Chiles v. Salazar: What you need to know about the U.S. Supreme Court case on conversion therapy" The American Psychiatric Association's position on conversion therapy  The American Psychological Association's position on conversion therapy The American Medical Association's position on conversion therapy  "LGBTQ Policy Spotlight: From Conversion "Therapy" Laws Protecting LGBTQ Youth" Check us out on YouTube, Instagram, Facebook, Bluesky, and X. Our website, we-dissent.org, has more information as well as episode transcripts.

From a bathroom nowhere near you. In the Tina Peters case, there may be too many cooks in the kitchen, and they're making lots of noise. Lot's of politics are involved with overturning a judge again. Crafting just the right argument. An Amicus is, by definition, a description of the facts. There is a huge opinion coming out soon. They cannot throw another magistrate under the bus. Stick to the law and how they violated the Constitution. This will be a massive case for future positions. It was punitive and cruel behavior by the state. No attorney's were able to figure this out? There was so much evidence piled up against the dims. Yup, they all F'd up. Remember, Colorado tried to keep Trump off the ballot. Please don't call the wrong people. Make the appropriate complaints to the right people. Now would be a good time to pray for everyone involved in election fraud court cases.

When evil comes at you, defend yourself using their words and deeds. Amicus strategy takes many turns, but GROK likes it. The Tina Peters release delays seem deliberate. Hopefully, she will be home for Thanksgiving. People love America, but don't fight for it's warriors. The key is getting the right evidence into court. They had a template to fight Trump in each state. Corrupt AG's. The FBI and DHS has the documents they need. If we don't get rid of the machines, it's game over. Project 65 raises it's ugly head. Happiness includes the truth, and personal grooming with correct skin tones and color balance. BLM does corrupt politics in DC. The British have lots of problems. A story or two about the Serbian activist Ivan. The Biden's dismantled their country. A video of some traitors during a planning session. Remember, these teachers shape minds. Round two is coming for the George Floyd story. Getting tougher would work now for the DOJ. Sounds like Lenin class. Amping up for maximum damage. They don't even know they are being used. The strongest idea yet is still freedom.

Dahlia Lithwick welcomes retired federal judge Mark Wolf for his first ever podcast interview. The Reagan-appointed jurist made headlines last week with his searing indictment of the threat posed to the rule of law and democracy by the current administration. Judge Wolf opens up about his decision to leave the bench after decades of public service and the challenges faced by judges in the face of a president and a Justice Department showing scant regard for the rules.  Next, Dahlia is joined by California Attorney General Rob Bonta, who tells her, “If Trump breaks the law and hurts our state, we sue him.” Together, they discuss the urgency of justice in response to the tactics employed by the Trump administration. As Democratic AGs band together to sue against unlawful executive actions, Bonta explains their strategies in securing injunctions against the administration.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dahlia Lithwick welcomes retired federal judge Mark Wolf for his first ever podcast interview. The Reagan-appointed jurist made headlines last week with his searing indictment of the threat posed to the rule of law and democracy by the current administration. Judge Wolf opens up about his decision to leave the bench after decades of public service and the challenges faced by judges in the face of a president and a Justice Department showing scant regard for the rules.  Next, Dahlia is joined by California Attorney General Rob Bonta, who tells her, “If Trump breaks the law and hurts our state, we sue him.” Together, they discuss the urgency of justice in response to the tactics employed by the Trump administration. As Democratic AGs band together to sue against unlawful executive actions, Bonta explains their strategies in securing injunctions against the administration.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dahlia Lithwick welcomes retired federal judge Mark Wolf for his first ever podcast interview. The Reagan-appointed jurist made headlines last week with his searing indictment of the threat posed to the rule of law and democracy by the current administration. Judge Wolf opens up about his decision to leave the bench after decades of public service and the challenges faced by judges in the face of a president and a Justice Department showing scant regard for the rules.  Next, Dahlia is joined by California Attorney General Rob Bonta, who tells her, “If Trump breaks the law and hurts our state, we sue him.” Together, they discuss the urgency of justice in response to the tactics employed by the Trump administration. As Democratic AGs band together to sue against unlawful executive actions, Bonta explains their strategies in securing injunctions against the administration.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

Harry talks to Marty Lederman, the former Deputy Assistant Attorney General who authored an amicus brief with a legal discovery that has shaken the Administration's attempt to deploy the National Guard to Chicago and other Democrat-led cities. Marty and Harry explain the critical oversight in the administration's reasoning, and they think through what a bruising legal defeat would mean for the effort to put boots on the ground in American cities. It's a possible game changer in a case Harry has called a "moment of truth for the High Court." Mentioned in this episode:  Harry's Substack about the stakes of this case: https://harrylitman.substack.com/p/moment-of-truth-for-the-high-court The Supreme Court's request for briefs on the phrase "the regular forces": https://www.supremecourt.gov/orders/courtorders/102925zr_hgci.pdf Marty Lederman's expanded brief on the phrase "the regular forces": https://www.supremecourt.gov/DocketPDF/25/25A443/384148/20251110232925983_25A443.Lederman.Supplemental.Amicus.Brief.1110.pdf Illinois and Chicago's expanded brief on the phrase "the regular forces": https://www.supremecourt.gov/DocketPDF/25/25A443/384145/20251110210604383_Illinois%20Supplemental%20Letter%20Brief%20Master%20Final%20To%20File%20PDFA.pdf  The administration's expanded brief on the phrase "the regular forces": https://www.supremecourt.gov/DocketPDF/25/25A443/384115/20251110170907870_25a443%20Trump%20v.%20Illinois%20-%20Supp.%20Letter%20Br.pdf Learn more about your ad choices. Visit megaphone.fm/adchoices

The Republican-appointed Supreme Court justices have been treating the Trump administration with such extreme deference that we were honestly a little flummoxed listening to this week's arguments over his “Liberation Day” tariffs. Shockingly, during Wednesday's arguments in Learning Resources v. Trump and Trump v. V.O.S. Selections, it seemed like the justices were in fact, concerned with presidential overreach. But was this a true bridge-too-far-moment, or were they more concerned about their own pocketbooks? This week, Dahlia Lithwick and Mark Joseph Stern discussed the arguments with Marc Busch, the Karl F. Landegger Professor of International Business Diplomacy at the Edmund A. Walsh School of Foreign Service at Georgetown University. Busch is an expert on international trade policy and law, and signed onto an amicus brief on behalf of trade scholars explaining the history and context of IEEPA.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Republican-appointed Supreme Court justices have been treating the Trump administration with such extreme deference that we were honestly a little flummoxed listening to this week's arguments over his “Liberation Day” tariffs. Shockingly, during Wednesday's arguments in Learning Resources v. Trump and Trump v. V.O.S. Selections, it seemed like the justices were in fact, concerned with presidential overreach. But was this a true bridge-too-far-moment, or were they more concerned about their own pocketbooks? This week, Dahlia Lithwick and Mark Joseph Stern discussed the arguments with Marc Busch, the Karl F. Landegger Professor of International Business Diplomacy at the Edmund A. Walsh School of Foreign Service at Georgetown University. Busch is an expert on international trade policy and law, and signed onto an amicus brief on behalf of trade scholars explaining the history and context of IEEPA.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

“The Chief Justice… is presiding over the end of the rule of law in America”. That quote did not come from host Dahlia Lithwick, but this week's guest, former Federal Circuit Court Judge and George H. W. Bush appointee, J Michael Luttig. On this week's show, Judge Luttig explains the unprecedented split we're seeing between the federal courts and the highest court in the land in response to Trump's lawlessness on everything from tariffs, to due process, to deploying the National Guard, and what it all means for the future of American democracy.  Next, Dahlia talks to the CEO of the small family business at the center of the tariffs case that will be argued at SCOTUS on Wednesday. Rick Woldenberg of Learning Resources explains why he's standing up to Trump's monarchic power grab, and why he sees himself standing shoulder-to-shoulder with James Madison. Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

“The Chief Justice… is presiding over the end of the rule of law in America”. That quote did not come from host Dahlia Lithwick, but this week's guest, former Federal Circuit Court Judge and George H. W. Bush appointee, J Michael Luttig. On this week's show, Judge Luttig explains the unprecedented split we're seeing between the federal courts and the highest court in the land in response to Trump's lawlessness on everything from tariffs, to due process, to deploying the National Guard, and what it all means for the future of American democracy.  Next, Dahlia talks to the CEO of the small family business at the center of the tariffs case that will be argued at SCOTUS on Wednesday. Rick Woldenberg of Learning Resources explains why he's standing up to Trump's monarchic power grab, and why he sees himself standing shoulder-to-shoulder with James Madison. Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

Bulldozers and bulwarks are the twin themes of this week's show, as Dahlia Lithwick is joined by Joyce White Vance, a longtime federal prosecutor and clarion voice in defense of the rule of law, despite its flaws. As Pam Bondi's Justice department chases down the President's opponents, Congress walks away from its constitutional duties, and the highest court in the land struggles to find a presidential demand too outrageous to rubber stamp, it's no wonder many Americans are exhausted by the attempt  to toggle between hope and despair. Lithwick and Vance discuss the many challenges to the integrity of the justice system and ponder what ordinary people can do to bolster vital democratic institutions under siege. Vance's new book, 'Giving Up is Unforgivable,' serves as a manual for citizens who understand that surviving this moment (and thriving after it) is a massive team project. It's okay to huff a little hopium sometimes, but only if it's the good stuff.  Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices